These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 31308074)

  • 21. Induction Therapy, Rejection, and Graft Outcomes in Pediatric and Adolescent Kidney Transplant Recipients.
    Mincham CM; Wong G; Teixeira-Pinto A; Kennedy S; Alexander S; Larkins N; Lim WH
    Transplantation; 2017 Sep; 101(9):2146-2151. PubMed ID: 28832451
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mammalian Target of Rapamycin Inhibitors and Clinical Outcomes in Adult Kidney Transplant Recipients.
    Badve SV; Pascoe EM; Burke M; Clayton PA; Campbell SB; Hawley CM; Lim WH; McDonald SP; Wong G; Johnson DW
    Clin J Am Soc Nephrol; 2016 Oct; 11(10):1845-1855. PubMed ID: 27445164
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recipient Comorbidity and Survival Outcomes After Kidney Transplantation: A UK-wide Prospective Cohort Study.
    Wu DA; Robb ML; Forsythe JLR; Bradley C; Cairns J; Draper H; Dudley C; Johnson RJ; Metcalfe W; Ravanan R; Roderick P; Tomson CRV; Watson CJE; Bradley JA; Oniscu GC
    Transplantation; 2020 Jun; 104(6):1246-1255. PubMed ID: 31449188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of deceased donor with acute kidney injury on subsequent kidney transplant outcomes-an ANZDATA registry analysis.
    Pei J; Cho Y; See YP; Pascoe EM; Viecelli AK; Francis RS; van Eps C; Isbel NM; Campbell SB; Clayton PA; Chapman J; Collins M; Lim W; Tang W; Wong G; Hawley CM; Johnson DW
    PLoS One; 2021; 16(3):e0249000. PubMed ID: 33765036
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk factors of long-term graft loss in renal transplant recipients with chronic allograft dysfunction.
    Khalkhali HR; Ghafari A; Hajizadeh E; Kazemnejad A
    Exp Clin Transplant; 2010 Dec; 8(4):277-82. PubMed ID: 21143092
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interleukin-2 receptor antibody reduces rejection rates and graft loss in live-donor kidney transplant recipients.
    Lim WH; Chang SH; Chadban SJ; Campbell SB; Dent H; Russ GR; McDonald SP
    Transplantation; 2009 Nov; 88(10):1208-13. PubMed ID: 19935375
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Donor catecholamine use reduces acute allograft rejection and improves graft survival after cadaveric renal transplantation.
    Schnuelle P; Lorenz D; Mueller A; Trede M; Van Der Woude FJ
    Kidney Int; 1999 Aug; 56(2):738-46. PubMed ID: 10432416
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trends in kidney transplantation in Australia and New Zealand, 1993-2004.
    Chang SH; Russ GR; Chadban SJ; Campbell SB; McDonald SP
    Transplantation; 2007 Sep; 84(5):611-8. PubMed ID: 17876274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peak panel reactive antibody, cancer, graft, and patient outcomes in kidney transplant recipients.
    Lim WH; Chapman JR; Wong G
    Transplantation; 2015 May; 99(5):1043-50. PubMed ID: 25539466
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The implications of acute rejection for allograft survival in contemporary U.S. kidney transplantation.
    Lentine KL; Gheorghian A; Axelrod D; Kalsekar A; L'italien G; Schnitzler MA
    Transplantation; 2012 Aug; 94(4):369-76. PubMed ID: 22836133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Parental donors in live-donor kidney transplantation associated with increased rejection rates and reduced glomerular filtration rates.
    Lim WH; Chang SH; Coates PT; McDonald SP
    Transplantation; 2007 Oct; 84(8):972-80. PubMed ID: 17989602
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term improvement of deceased donor renal allograft survival since 1996: a single transplant center study.
    Sola E; Gonzalez-Molina M; Cabello M; Burgos D; Ramos J; Gutierrez C; Lopez V; Soler J; de la Vega E; Hernandez D
    Transplantation; 2010 Mar; 89(6):714-20. PubMed ID: 20035250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term kidney regraft survival from deceased donors: risk factors and outcomes in a single center.
    Arnol M; Prather JC; Mittalhenkle A; Barry JM; Norman DJ
    Transplantation; 2008 Oct; 86(8):1084-9. PubMed ID: 18946346
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk factors for allograft failure in United kingdom renal transplant recipients treated with cyclosporine A.
    He X; Johnston A
    Transplantation; 2005 Apr; 79(8):953-7. PubMed ID: 15849549
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of acute rejection vs new-onset diabetes after transplant on transplant outcomes in pediatric kidney recipients: analysis of the Organ Procurement and Transplant Network/United Network for Organ Sharing (OPTN/UNOS) database.
    Mehrnia A; Le TX; Tamer TR; Bunnapradist S
    Pediatr Transplant; 2016 Nov; 20(7):952-957. PubMed ID: 27578397
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcomes of Kidney Transplantation Abroad: A Single-Center Canadian Cohort Study.
    Quach K; Sultan H; Li Y; Famure O; Kim SJ
    Prog Transplant; 2016 Mar; 26(1):5-12. PubMed ID: 27136244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kidney Transplant Outcomes in elderly Recipients: An Australia and New Zealand Dialysis and Transplant (ANZDATA) Registry Study.
    Doucet BP; Cho Y; Campbell SB; Johnson DW; Hawley CM; Teixeira-Pinto ARM; Isbel NM
    Transplant Proc; 2021; 53(6):1915-1926. PubMed ID: 34275599
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association Between Duration of Delayed Graft Function, Acute Rejection, and Allograft Outcome After Deceased Donor Kidney Transplantation.
    Lim WH; Johnson DW; Teixeira-Pinto A; Wong G
    Transplantation; 2019 Feb; 103(2):412-419. PubMed ID: 29762458
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term outcomes of kidney transplant recipients with end-stage kidney disease attributed to presumed/advanced glomerulonephritis or unknown cause.
    Lim WH; Wong G; McDonald SP; Chakera A; Luxton G; Isbel NM; Pilmore HL; Barbour T; Hughes P; Chadban SJ
    Sci Rep; 2018 Jun; 8(1):9021. PubMed ID: 29899355
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute rejection, T-cell-depleting antibodies, and cancer after transplantation.
    Lim WH; Turner RM; Chapman JR; Ma MK; Webster AC; Craig JC; Wong G
    Transplantation; 2014 Apr; 97(8):817-25. PubMed ID: 24521777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.